Sponsored By

NutraGenesis Receives U.S. Patent

The U.S. Patent and Trademark Office has issued NutraGenesis a patent covering its WellBody 365® nutraceutical ingredient, a combination of beta glucan and ashwagandha.

January 7, 2014

1 Min Read
NutraGenesis Receives U.S. Patent

BRATTLEBORO, Vt.The U.S. Patent and Trademark Office has issued NutraGenesis a patent covering its WellBody 365® nutraceutical ingredient, a combination of beta glucan and ashwagandha. The patent covers the composition that enhances immune activity during chronic stress by increasing cytokines and phagocytosis, NutraGenesis said. The ingredient contains a clinically tested, multi-patented immunomodulating Maitake mushroom extract with the standardized ashwagandha extract Sensoril®.

WellBody 365® represents a departure from traditional immune-modulators that simply address immune support," said company president and managing director Suzanne McNeary. "Patented WellBody 365® is the next-generation immune nutraceutical that provides immune modulation as well as dramatic resistance to stress for broad spectrum, daily support and protection of immune function."

In July 2013, research in Research Journal of Life Sciences found Sensoril® provides resistance to heat stress and pain.

Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.

You May Also Like